Eli Lilly's 21.71 Billion Trading Volume Lands 15th in Market Activity

On April 2, 2025, Eli Lilly and Company (Eli) recorded a trading volume of 21.71 billion, ranking 15th in the day's stock market activity. The company's stock price increased by 1.61%.

Eli Lilly and Company has acquired the FXR program, along with all related commercial and intellectual property rights. This strategic move is expected to enhance Eli's portfolio and potentially drive future growth. The financial terms of the acquisition have not been disclosed, but the deal underscores Eli's commitment to expanding its capabilities in the pharmaceutical sector.

Hims & Hers has expanded its weight-loss offerings on its telehealth platform by adding Eli Lilly's Zepbound prescription and generic liraglutide. This collaboration is likely to boost Eli's market presence in the weight management segment, further solidifying its position in the healthcare industry.